STOCK TITAN

Lument Finance director granted 37K shares

Lument Finance Trust, Inc. (LFT) director James Christopher Hunt reported an acquisition of 37,111 shares of common stock on August 24, 2026.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lument Finance Trust, Inc. (LFT) director James Christopher Hunt reported an acquisition of 37,111 shares of common stock on August 24, 2026. The shares were received as director fees paid in stock at a reported value of $0.6737 per share, bringing his direct holdings to 747,089 shares.

Positive

  • None.

Negative

  • None.
Insider Hunt James Christopher
Role Director
Type Security Shares Price Value
Grant/Award common stock F1 37,111 $0.6737 $25K
Holdings After Transaction: common stock — 747,089 shares (Direct)
Footnotes (1)
  1. F1. Director fees paid in stock.
Shares acquired 37,111 shares of common stock Grant/award acquisition on August 24, 2026
Reported value per share $0.6737 per share Director fees paid in stock for 37,111 shares
Shares owned after transaction 747,089 shares Direct holdings of James Christopher Hunt after the grant
director fees financial
"Director fees paid in stock."
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
beneficial ownership financial
"total_shares_following_transaction": "747089.0000""
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What insider transaction did LFT report for James Christopher Hunt?

Lument Finance Trust, Inc. reported that director James Christopher Hunt acquired 37,111 shares of common stock on August 24, 2026 as a grant/award of director fees paid in stock.

Was the LFT Form 4 transaction a market purchase or a stock grant?

The Form 4 for LFT shows a grant/award acquisition, not a market purchase. The footnote states the transaction represents director fees paid in stock, coded as an “A” (Grant, award, or other acquisition).

At what value were the LFT shares awarded to James Christopher Hunt?

The reported value for the LFT common stock awarded to James Christopher Hunt was $0.6737 per share for the 37,111-share stock fee grant.

How many LFT shares does James Christopher Hunt hold after this transaction?

After the August 24, 2026 stock fee grant, James Christopher Hunt directly holds 747,089 shares of Lument Finance Trust, Inc. common stock as reported in the Form 4.

Was the LFT Form 4 transaction under a Rule 10b5-1 trading plan?

No. The Form 4’s Rule 10b5-1 checkbox is not checked, and the filing does not indicate that the director fee stock grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hunt James Christopher

(Last)(First)(Middle)
C/O LUMENT FINANCE TRUST, INC.
230 PARK AVENUE, 20TH FLOOR

(Street)
NEW YORK NEW YORK 10169

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Lument Finance Trust, Inc. [ LFT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
common stock08/24/2026A37,111A(1)$0.6737747,089D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Director fees paid in stock.
/s/ Michele Halickman, Attorney-in-Fact08/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)